Solitary plasmacytoma in the setting of Langerhans cell histiocytosis.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D010954:Plasmacytoma / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin